ATE352039T1 - Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung - Google Patents

Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung

Info

Publication number
ATE352039T1
ATE352039T1 AT02017004T AT02017004T ATE352039T1 AT E352039 T1 ATE352039 T1 AT E352039T1 AT 02017004 T AT02017004 T AT 02017004T AT 02017004 T AT02017004 T AT 02017004T AT E352039 T1 ATE352039 T1 AT E352039T1
Authority
AT
Austria
Prior art keywords
activity
determining
thymidinkinase
thymidine kinase
thymidine
Prior art date
Application number
AT02017004T
Other languages
English (en)
Inventor
Anders Oehrvik
Staffan Eriksson
Original Assignee
Diasorin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diasorin Ab filed Critical Diasorin Ab
Application granted granted Critical
Publication of ATE352039T1 publication Critical patent/ATE352039T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT02017004T 2002-07-27 2002-07-27 Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung ATE352039T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02017004A EP1385005B1 (de) 2002-07-27 2002-07-27 Verfahren zur Bestimmung der Aktivität von Thymidinkinase-1 und dessen Verwendung

Publications (1)

Publication Number Publication Date
ATE352039T1 true ATE352039T1 (de) 2007-02-15

Family

ID=29797201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02017004T ATE352039T1 (de) 2002-07-27 2002-07-27 Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung

Country Status (7)

Country Link
US (1) US20060035295A1 (de)
EP (1) EP1385005B1 (de)
JP (1) JP2005533519A (de)
AT (1) ATE352039T1 (de)
AU (1) AU2003250938A1 (de)
DE (1) DE60217665T2 (de)
WO (1) WO2004013630A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004029156D1 (de) 2003-05-16 2010-10-28 Arocell Ab Prognose des verlaufs einer krebserkrankung
CA2598726C (en) * 2005-02-25 2014-02-18 Ronnerbol Holding Ab A method and kit for determination of thymidine kinase activity and use thereof
US8501419B2 (en) * 2007-05-23 2013-08-06 Arocell Ab Exposed proliferation-related peptides, ligands and methods employing the same
CA2699385A1 (en) * 2007-09-14 2009-03-19 Ventana Medical Systems, Inc. Prostate cancer biomarkers
WO2009058898A2 (en) 2007-10-29 2009-05-07 Veterinary Diagnostics Institute, Inc. Method and apparatus for diagnoses of hemangiosarcoma in mammals
GB0722449D0 (en) * 2007-11-15 2007-12-27 Univ Abertay Dundee bIOASSAY
US9429518B2 (en) 2010-05-14 2016-08-30 Csens Ab Kit and method
EP2457916A1 (de) * 2010-11-16 2012-05-30 DiaSorin S.p.A. Verbindung zur kovalenten Anheftung der chemolumineszenten Sonde N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) zur Bestimmung von Molekülen und Verwendungen dafür
JP6233834B2 (ja) * 2013-08-27 2017-11-22 国立大学法人 長崎大学 キノンを検出するための化合物および該化合物を用いたキノンの検出方法
ES2983797T3 (es) * 2018-08-31 2024-10-24 Hoffmann La Roche Timidina cinasa (TK-1) en índices pronóstico para LDLBG
KR20220057566A (ko) * 2019-09-05 2022-05-09 미토레인보우 테라퓨틱스, 인크. 미토콘드리아 dna 고갈 장애의 치료

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE453514B (sv) * 1982-05-14 1988-02-08 Gronowitz Jan Sim0N Sett att bestemma deoxitymidinkinas-dtk-isoenzymnivaer i kroppsvetska eller cellprov och anvendningen av forfarandet for isoenzymtypning
EP1142991A3 (de) * 1993-08-06 2003-03-12 Brigham Young University Technology Transfer Office Monoklonale Antikörper gegen Isozyme der Thymidinkinase

Also Published As

Publication number Publication date
EP1385005A1 (de) 2004-01-28
US20060035295A1 (en) 2006-02-16
WO2004013630A1 (en) 2004-02-12
EP1385005B1 (de) 2007-01-17
DE60217665D1 (de) 2007-03-08
JP2005533519A (ja) 2005-11-10
DE60217665T2 (de) 2007-10-11
AU2003250938A1 (en) 2004-02-23

Similar Documents

Publication Publication Date Title
BRPI0518086A (pt) métodos para tratamento de cáncer, métodos de avaliação de fosforilação ou ativação de her e método de identificação
ATE352039T1 (de) Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung
ATE157123T1 (de) Verfahren und vorrichtung zur amperometrischen diagnostischen analyse
CY1111612T1 (el) Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her
ATE246356T1 (de) Vorrichtung zum vorhersagen von physiologischen messwerten
WO2000000636A3 (en) In vivo determination of metabolic function for use in therapy management
EP0850011A4 (de) Verfahren zur nicht-invasiven messung der blutanalyse mit hilfe einer verbesserten optischen schnittstelle
ATE352252T1 (de) Verfahren zur nicht invasiven analytenmessung
BR0312534A (pt) método de identificação de um tumor, método para a identificação de células de tumor, método para prever a resposta de um indivìduo diagnosticado com um tumor de her2-positivo, método para a identificação de um individuo responsivo ao tratamento com anticorpo anti-her2 e métodos de tratamento de um paciente e artigo de manufatura
ATE550642T1 (de) Verfahren zur messung von 1,5-anhydroglucitol in vollblut
Kowalchuk et al. Acid–base regulations a comparison of quantitative methods
CY1115640T1 (el) Διαγνωση και αγωγη εναντι της σχιζοφρενειας
ATE71734T1 (de) Teststreifen zur aufnahme von blutzuckertagesprofilen und verfahren zu seiner herstellung sowie dessen verwendung.
ATE496635T1 (de) Verfahren und zusammensetzungen zur hemmung, prävention oder verringerung des tumorzellwachstums bei patienten, die gegen die antineoplastischen wirkungen einer antiöstrogen- therapie resistent sind
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
NO953770L (no) Analysemetode
DE60225903D1 (de) In-vivo verfahren zur messung von auf der haut oder dessen komponenten bindenden aktiven chemischen substanzen
BRPI0412110A (pt) genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos
KR0138503B1 (en) Method to detect bone and other connective tissue disorders in humans and animals
BR0317910A (pt) Uso de um fator hematopoiético; de um polinucleotìdeo que codifica o dito fato; de uma célula tronco neuronal; e de gcsf e/ou de derivados de gcsf; métodos para identificar um composto; composto assim identificado, bem como métodos para intensificar a viabilidade de uma cultura de célula neural
ES8404055A1 (es) Procedimiento de preparacion de un nuevo reactivo para el diagnostico de las parasitosis y de las alergias.
ATE432997T1 (de) Therapieüberwachung für tumoren unter benutzung acc133 mrna
BRPI0512336A (pt) métodos de diagnósticos para osteoporose
DE60326871D1 (de) Verfahren zur dosierung von ngf zur in vitro diagnose von brustkrebs und therapeutische verwendung
Sharma et al. Effects of oral exposure of acrylamide on plasma levels of thyroid hormones and haematological parameters in the Swiss albino mice

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties